Item 5. Other Information
Item
5. Other Information
None.
Item
6. Exhibits
Exhibit
Number
Description
10.1*
Business Loan Agreement with Renasant Bank pursuant to the Paycheck Protection Program, dated April 27, 2020
10.2
Second Amendment, dated as of April 1, 2020, to the Loan and Security Agreement by and among Harrow Health, Inc., several of its wholly-owned subsidiaries and the Lenders named therein (incorporated herein by reference to Exhibit 10 to the Current Report on Form 8-K of Harrow Health, Inc. filed with the Securities and Exchange Commission on April 3, 2020)
31.1*
Certification of Mark L. Baum, principal executive officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes- Oxley Act of 2002.
31.2*
Certification of Andrew R. Boll, principal financial and accounting officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes- Oxley Act of 2002.
32.1**
Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Mark L. Baum, principal executive officer, and Andrew R. Boll, principal financial and accounting officer.
101.INS*
Inline XBRL Instance
Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the
Inline XBRL document.
101.SCH*
Inline XBRL Taxonomy
Extension Schema Document
101.CAL*
Inline XBRL Taxonomy
Extension Calculation Linkbase Document
101.DEF*
Inline XBRL Taxonomy
Extension Definition Linkbase Document
101.LAB*
Inline XBRL Taxonomy
Extension Label Linkbase Document
101.PRE*
Inline XBRL Taxonomy
Extension Presentation Linkbase Document
104
The cover page from
the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2020, has been formatted in Inline XBRL.
*
Filed herewith.
**
Furnished herewith.
45
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
Harrow Health, Inc.
Dated: August
10, 2020
By:
/s/
Mark L. Baum
Mark L. Baum
Chief Executive Officer and Director
(Principal Executive Officer)
By:
/s/
Andrew R. Boll
Andrew R. Boll
Chief Financial Officer (Principal Financial
and Accounting Officer)
46
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.